NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/13/2022
Back to search
Official data from USPTO
NV NEURVANA MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
12/13/2022
Trademark type
Combined
Nice classes
10
Filing date
05/02/2017
Registration date
12/13/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/13/2022
Last transaction
12/13/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/08/2016
First use in commerce
07/12/2017
Drawing code
3
Owner type
16
Owner location
Tustin, CA, US
Examiner
WEIGLE, KATHERINE
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a purple square with rounded corners in which the letters "NV" appear in gray. To the right is the wording NEURVANA MEDICAL in gray letters, except for the first "N" and "V," which are purple.
Holders and representatives
Holders
Neurvana Medical, LLC
Representatives
PETER J. GLUCK PATNSTR, APC
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical devicesminimally invasive neurovascular devices for the treatment of neurological conditions
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/13/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/27/2022
PUBO
PUBLISHED FOR OPPOSITION
09/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/07/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/19/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/16/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
08/09/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
02/01/2021
DOCK
ASSIGNED TO EXAMINER
01/19/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/31/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/31/2020
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/30/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
01/30/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/30/2018
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
01/30/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/29/2018
GNSL
LETTER OF SUSPENSION E-MAILED
01/29/2018
IUAA
USE AMENDMENT ACCEPTED
01/29/2018
CNSL
SUSPENSION LETTER WRITTEN
01/29/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/29/2018
GRML
CORRESPONDENCE E-MAILED
01/29/2018
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
01/29/2018
IUAF
USE AMENDMENT FILED
01/29/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/28/2018
EAAU
TEAS AMENDMENT OF USE RECEIVED
01/28/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/28/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/28/2017
GNRT
NON-FINAL ACTION E-MAILED
07/28/2017
CNRT
NON-FINAL ACTION WRITTEN
07/28/2017
DOCK
ASSIGNED TO EXAMINER
07/28/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/08/2017
NWAP
NEW APPLICATION ENTERED
05/05/2017
Continuous trademark protection
Get notified about every new filing that threatens NV NEURVANA MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.